Brazikumab (Anti-IL-23)
Product Specifications
CAS Number
1610353-18-8
Synonyms
AMG 139; MEDI2070
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Brazikumab (Anti-IL-23) is a human IgG2 monoclonal antibody that selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for research on Crohn's disease. MW: 144.82 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog